Pediatric Press Releases
Prevention and Treatment of Pediatric Obesity: Utilizing the Spectrum of Available Tools
Given the rapid rise of pediatric obesity, it is important that clinicians have expert perspectives about the screening, diagnosis, and treatment to minimize the risk of obesity-related complications later in life.
Early-term births associated with ADHD symptoms
Children born before 39 weeks are more likely to experience symptoms related to ADHD, according to data published in The Journal of Pediatrics. Co-author Nancy E. Reichman, PhD, is a professor in the neonatology division at Robert Wood Johnson Medical School at Rutgers
Identifying and Treating Severe Hypoglycemia in Pediatric Patients with Diabetes
Hypoglycemia is a clinical challenge for providers who treat pediatric patients with diabetes. Until further research into improving hypoglycemia is conducted, clinicians should rely on their judgment of the severity of hypoglycemic events in their pediatric patients rather than on
Six Procedures Account for Two-Thirds of Pediatric Postop Revisits
Tonsillectomy/adenoidectomy, appendectomy account for most postsurgical pediatric emergency department visits MONDAY, Aug. 29, 2022 (HealthDay News) — Six pediatric surgical procedures account for most postoperative hospital and emergency department visits, according to a research letter published in the Aug. 23/30
Researchers identify factors that predict future lung function in children with asthma
Obesity, fractional exhaled nitric oxide and maximum bronchodilator reversibility were among the factors that precited lower FEV1 over time among children with asthma, according to a study in The Journal of Allergy and Clinical Immunology.
Adult epilepsy treatment reduces seizures in children
A surgical treatment commonly used to reduce epileptic seizures in adults also is effective and safe for children, according to a Rutgers study.
Children’s mental health is in crisis
As pandemic stressors continue, kids’ mental health needs to be addressed in schools.
MIS-C Diagnosed More Often in Black, Hispanic Children
Researchers from The George Washington University
FDA Says Children as Young as 3 Years Old can Take Epclusa for Hepatitis C
Under an FDA-approved expansion of the pediatric indication, children aged as young as 3 years are now able to receive Epclusa for the treatment of chronic hepatitis C virus regardless of HCV genotype or severity. The FDA originally approved Epclusa
Most Pediatric Rheumatology Providers Find Telehealth Lacking for Clinical Assessment
In a recent survey, pediatric rheumatology providers reported that telehealth visits during the COVID-19 pandemic were inferior to in-person appointments for complete clinical assessments.
Latest Event
Recent Articles
